EXOMIND (BTL-995) for the Reduction of Binge-eating
Clinical trial NCT06894615 · COMPLETED
Trial details
- NCT number
- NCT06894615
- Sponsor
- BTL Industries Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-11
- Primary completion
- 2023-12-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.